EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeit

Association between anti-PLA2R antibody status and clinical remission in primary membranous nephropathy: a systematic review and meta-analysis

Qing He, Yiwei Shang, Zimo Zhao, Qikai Luo, Yourou Zhou, Qiang He, Juan Jin, Nan Yang

International Urology and Nephrology · 27.07.2026 · 58 (12) · 5435-5447

DOI: 10.1007/s11255-026-05301-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Urology and Nephrology, online erschienen am 27.07.2026. Verfasst von Qing He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Ha…. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, Receptors, Phospholipase A2, Autoantibodies. Die Arbeit nennt 50 Literaturangaben. Gefördert von: The Central Government Guides Local Science and Technology Development Fund Projects, National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The anti-PLA2R antibody is a key biomarker for primary membranous nephropathy, and clarifying its association with clinical remission is crucial for optimizing prognostic assessment and clinical management. This study aimed to systematically evaluate the correlation between anti-PLA2R antibody status and clinical remission in patients with PMN. METHODS: Relevant cohort studies were systematically searched and strictly screened from domestic and international databases in accordance with predefined inclusion and exclusion criteria. A total of 12 eligible cohort studies involving 1664 PMN patients were included in this meta-analysis. RESULTS: Pooled quantitative analysis showed that anti-PLA2R antibody-positive patients had a significantly lower clinical remission rate compared with seronegative counterparts. The pooled RR was 0.75 (95% CI 0.61-0.92), P = 0.007, indicating a statistically significant difference between the two groups. The test for subgroup differences showed marginally different effect sizes across the three groups (X2 = 5.83, df = 2, P = 0.05), suggesting that divergent anti-PLA2R testing methods partly accounted for the overall high inter-study heterogeneity (I2 = 71%). CONCLUSION: Anti-PLA2R positivity predicts poorer 6-month remission in adult PMN, supporting KDIGO-guided early immunosuppression for high-risk patients. Heterogeneity mainly stems from inconsistent detection assays, and unified testing improves prognostic accuracy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranousReceptors, Phospholipase A2AutoantibodiesHumansRemission InductionBiomarkersPrognosis

Stichwörter der Autor:innen

Anti-PLA2R antibodiesComplete remissionPartial remissionPrimary membranous nephropathyPrognosis

Substanzen

Receptors, Phospholipase A2AutoantibodiesPLA2R1 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, Zhejiang, People's Republic of China.
  • Zhejiang Key Laboratory of Research and Translation for Kidney Deficiency-Stasis-Turbidity Disease, Zhejiang-Macau International Joint Laboratory of Integrated Traditional Chinese and Western Medicine for Nephrology and…
  • Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, Zhejiang, People's Republic of China. qianghe1973@126.…
  • Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, Zhejiang, People's Republic of China. lang_018@163.com.
  • Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, Zhejiang, People's Republic of China. y15698105812@163…

Förderung

  • The Central Government Guides Local Science and Technology Development Fund Projects
  • National Science and Technology Major Project

Zitieren

APA

He, Q., Shang, Y., Zhao, Z., Luo, Q., Zhou, Y., He, Q., Jin, J., & Yang, N. (2026). Association between anti-PLA2R antibody status and clinical remission in primary membranous nephropathy: a systematic review and meta-analysis. International Urology and Nephrology, 58(12), 5435-5447. https://doi.org/10.1007/s11255-026-05301-2

Vancouver

He Q, Shang Y, Zhao Z, Luo Q, Zhou Y, He Q, et al. Association between anti-PLA2R antibody status and clinical remission in primary membranous nephropathy: a systematic review and meta-analysis. International Urology and Nephrology. 2026;58(12):5435-5447. doi:10.1007/s11255-026-05301-2

BibTeX
@article{He2026,
  author = {He, Qing and Shang, Yiwei and Zhao, Zimo and Luo, Qikai and Zhou, Yourou and He, Qiang and Jin, Juan and Yang, Nan},
  title = {Association between anti-PLA2R antibody status and clinical remission in primary membranous nephropathy: a systematic review and meta-analysis},
  journal = {International Urology and Nephrology},
  year = {2026},
  volume = {58},
  number = {12},
  pages = {5435--5447},
  doi = {10.1007/s11255-026-05301-2}
}
Kostenlos starten →